Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where B. Nielsen is active.

Publication


Featured researches published by B. Nielsen.


Animal | 2016

Evaluation of in situ valine production by Bacillus subtilis in young pigs.

J.V. Nørgaard; Nuria Canibe; E. A. Soumeh; Bent Borg Jensen; B. Nielsen; Patrick Derkx; Mette Dines Cantor; K. Blaabjerg; Hanne Poulsen

Mutants of Bacillus subtilis can be developed to overproduce Val in vitro. It was hypothesized that addition of Bacillus subtilis mutants to pig diets can be a strategy to supply the animal with Val. The objective was to investigate the effect of Bacillus subtilis mutants on growth performance and blood amino acid (AA) concentrations when fed to piglets. Experiment 1 included 18 pigs (15.0±1.1 kg) fed one of three diets containing either 0.63 or 0.69 standardized ileal digestible (SID) Val : Lys, or 0.63 SID Val : Lys supplemented with a Bacillus subtilis mutant (mutant 1). Blood samples were obtained 0.5 h before feeding and at 1, 2, 3, 4, 5 and 6 h after feeding and analyzed for AAs. In Experiment 2, 80 piglets (9.1±1.1 kg) were fed one of four diets containing 0.63 or 0.67 SID Val : Lys, or 0.63 SID Val : Lys supplemented with another Bacillus subtilis mutant (mutant 2) or its parent wild type. Average daily feed intake, daily weight gain and feed conversion ratio were measured on days 7, 14 and 21. On day 17, blood samples were taken and analyzed for AAs. On days 24 to 26, six pigs from each dietary treatment were fitted with a permanent jugular vein catheter, and blood samples were taken for AA analysis 0.5 h before feeding and at 1, 2, 3, 4, 5 and 6 h after feeding. In experiment 1, Bacillus subtilis mutant 1 tended (P<0.10) to increase the plasma levels of Val at 2 and 3 h post-feeding, but this was not confirmed in Experiment 2. In Experiment 2, Bacillus subtilis mutant 2 and the wild type did not result in a growth performance different from the negative and positive controls. In conclusion, results obtained with the mutant strains of Bacillus subtilis were not better than results obtained with the wild-type strain, and for both strains, the results were not different than the negative control.


Acta Agriculturae Scandinavica Section A-animal Science | 2015

Tryptophan provision by dietary supplementation of a Bacillus subtilis mutant strain in piglets

A. Torres-Pitarch; B. Nielsen; Nuria Canibe; Bent Borg Jensen; Patrick Derkx; Mette Dines Cantor; K. Blaabjerg; Hanne Poulsen; J.V. Nørgaard

Abstract Supplementing Bacillus (B.) subtilis mutants selected to overproduce a specific amino acid (AA) may be an alternative method to provide essential AA in pig diets. Two experiments on a B. subtilis strain selected to overproduce Trp were conducted using 8-kg pigs fed Trp-deficient diets for 20 d. B. subtilis were supplied in a low or high dose in Experiments 1 and 2, respectively. The Trp-deficient diet (0.15 SID Trp:Lys) reduced (p < .05) both gain and feed intake of piglets compared to the positive control diet (0.17 SID Trp:Lys). Supplementation of the B. subtilis strain was not able to counterbalance the Trp deficiency in any of the two experiments. No effect of B. subtilis supplementation to piglet diets was observed on the plasma AA profile. In conclusion, this mutant strain of B. subtilis was not able to compensate a Trp deficiency in the tested doses.


Applied and Environmental Microbiology | 2018

Antimicrobial Susceptibility Testing and Tentative Epidemiological Cutoff Values for Five Bacillus Species Relevant for Use as Animal Feed Additives or for Plant Protection

Yvonne Agersø; Birgitte Stuer-Lauridsen; Karin Bjerre; Michelle Geervliet Jensen; Eric Johansen; Mads Bennedsen; Elke Brockmann; B. Nielsen

When commercializing bacterial strains, like Bacillus spp., for feed applications or plant bioprotection, it is required that the strains are free of acquired antimicrobial resistance genes that could potentially spread to pathogenic bacteria, thereby adding to the pool of resistance genes that may cause treatment failures in humans or animals. Conversely, if antimicrobial resistance is intrinsic to a bacterial species, the risk of spreading horizontally to other bacteria is considered very low. Reliable susceptibility test methods and interpretation criteria at the species level are needed to accurately assess antimicrobial resistance levels. In the present study, tentative ECOFFs for five Bacillus species were determined, and the results showed that the variation in MICs followed the respective species. Moreover, putative resistance genes, which were detected by whole-genome sequencing and suggested to be intrinsic rather that acquired, could explain the resistance phenotypes in most cases. ABSTRACT Bacillus megaterium (n = 29), Bacillus velezensis (n = 26), Bacillus amyloliquefaciens (n = 6), Bacillus paralicheniformis (n = 28), and Bacillus licheniformis (n = 35) strains from different sources, origins, and time periods were tested for the MICs for nine antimicrobial agents by the CLSI-recommended method (Mueller-Hinton broth, 35°C, for 18 to 20 h), as well as with a modified CLSI method (Iso-Sensitest [IST] broth, 37°C [35°C for B. megaterium], 24 h). This allows a proposal of species-specific epidemiological cutoff values (ECOFFs) for the interpretation of antimicrobial resistance in these species. MICs determined by the modified CLSI method were 2- to 16-fold higher than with the CLSI-recommended method for several antimicrobials. The MIC distributions differed between species for five of the nine antimicrobials. Consequently, use of the modified CLSI method and interpretation of resistance by use of species-specific ECOFFs is recommended. The genome sequences of all strains were determined and used for screening for resistance genes against the ResFinder database and for multilocus sequence typing. A putative chloramphenicol acetyltransferase (cat) gene was found in one B. megaterium strain with an elevated chloramphenicol MIC compared to the other B. megaterium strains. In B. velezensis and B. amyloliquefaciens, a putative tetracycline efflux gene, tet(L), was found in all strains (n = 27) with reduced tetracycline susceptibility but was absent in susceptible strains. All B. paralicheniformis and 23% of B. licheniformis strains had elevated MICs for erythromycin and harbored ermD. The presence of these resistance genes follows taxonomy suggesting they may be intrinsic rather than horizontally acquired. Reduced susceptibility to chloramphenicol, streptomycin, and clindamycin could not be explained in all species. IMPORTANCE When commercializing bacterial strains, like Bacillus spp., for feed applications or plant bioprotection, it is required that the strains are free of acquired antimicrobial resistance genes that could potentially spread to pathogenic bacteria, thereby adding to the pool of resistance genes that may cause treatment failures in humans or animals. Conversely, if antimicrobial resistance is intrinsic to a bacterial species, the risk of spreading horizontally to other bacteria is considered very low. Reliable susceptibility test methods and interpretation criteria at the species level are needed to accurately assess antimicrobial resistance levels. In the present study, tentative ECOFFs for five Bacillus species were determined, and the results showed that the variation in MICs followed the respective species. Moreover, putative resistance genes, which were detected by whole-genome sequencing and suggested to be intrinsic rather that acquired, could explain the resistance phenotypes in most cases.


Applied Microbiology and Biotechnology | 2017

Selection of Bacillus species for targeted in situ release of prebiotic galacto-rhamnogalacturonan from potato pulp in piglets

Carsten Jers; Mikael Lenz Strube; Mette Dines Cantor; B. Nielsen; Ole Brøsted Sørensen; Mette Boye; Anne S. Meyer

We have previously shown that galacto-rhamnogalacturonan fibers can be enzymatically extracted from potato pulp and that these fibers have potential for exerting a prebiotic effect in piglets. The spore-forming Bacillus species are widely used as probiotics in feed supplements for pigs. In this study, we evaluated the option for further functionalizing Bacillus feed supplements by selecting strains possessing the enzymes required for extraction of the potentially prebiotic fibers. We established that it would require production and secretion of pectin lyase and/or polygalacturonase but no or limited secretion of galactanase and β-galactosidase. By screening a library of 158 Bacillus species isolated from feces and soil, we demonstrated that especially strains of Bacillus amyloliquefaciens, Bacillus subtilis, and Bacillus mojavensis have the necessary enzyme profile and thus the capability to degrade polygalacturonan. Using an in vitro porcine gastrointestinal model system, we revealed that specifically strains of B. mojavensis were able to efficiently release galacto-rhamnogalacturonan from potato pulp under simulated gastrointestinal conditions. The work thus demonstrated the feasibility of producing prebiotic fibers via a feed containing Bacillus spores and potato pulp and identified candidates for future in vivo evaluation in piglets.


Archive | 2013

Determination of the valine requirements for growth in pigs from 8 to 18 kg

E. Assadi; J.V. Nørgaard; Nuria Canibe; Bent Borg Jensen; B. Nielsen; K. Blaabjerg; Hanne Poulsen

Pig diets are supplemented with crystalline amino acids (AA) to balance the AA profile. This is necessary to avoid poor nitrogen (N) utilization, urinary N excretion, and low growth rates. Valine (Val) is one of the branched-chain AA which cannot be synthesized by the animal and therefore is listed as indispensable AA. In European grower diets, Val is often the fifth limiting AA after lysine (Lys), methionine (Met), threonine (Thr), and tryptophan (Trp) and appears to be a deficient nutrient in pig feedstuffs in regard to the minimum requirement for pigs. The objective of this study was to determine the requirements of Val that supports the maximum animal performance.


Applied Microbiology and Biotechnology | 2014

Characterization of Bacillus spp. strains for use as probiotic additives in pig feed

Nadja Larsen; Line Thorsen; Elmer Nayra Kpikpi; Birgitte Stuer-Lauridsen; Mette Dines Cantor; B. Nielsen; Elke Brockmann; Patrick Derkx; Lene Jespersen


Livestock Science | 2012

First studies on a new concept for amino acid provision through B. subtilis in situ valine production in young pigs

J.V. Nørgaard; Nuria Canibe; B. Nielsen; D. Carlson; I. Knap; Mette Dines Cantor; Hanne Poulsen


Biotechnology Letters | 2017

Development of Bacillus subtilis mutants to produce tryptophan in pigs

Karin Bjerre; Mette Dines Cantor; J.V. Nørgaard; Hanne Poulsen; K. Blaabjerg; Nuria Canibe; Bent Borg Jensen; Birgitte Stuer-Lauridsen; B. Nielsen; Patrick Derkx


Journal of Animal Science | 2016

Growth of and valine production by a Bacillus subtilis mutant in the small intestine of pigs1

Nuria Canibe; H. V. Poulsen; J.V. Nørgaard; B. Nielsen; Mette Dines Cantor; Patrick Derkx; Hanne Poulsen; K. Blaabjerg; B. B. Jensens


Journal of Animal Science | 2016

Effect of Bacillus subtilis mutants on growth performance of piglets fed tryptophan- and valine-deficient diets

J.V. Nørgaard; Nuria Canibe; E. A. Soumeh; Bent Borg Jensen; B. Nielsen; Patrick Derkx; Mette Dines Cantor; K. Blaabjerg; Hanne Poulsen

Collaboration


Dive into the B. Nielsen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge